HK Stock MarketDetailed Quotes

HUMAN HEALTH (01419)

Watchlist
  • 0.810
  • 0.0000.00%
Market Closed Apr 24 09:00 CST
307.44MMarket Cap11.10P/E (TTM)

HUMAN HEALTH (01419) Income Statement

All
YOY yoy
Hide blank lines yoy
(Q6)Dec 31, 2025
(FY)Jun 30, 2025
(Q6)Dec 31, 2024
(FY)Jun 30, 2024
(Q9)Mar 31, 2024
(Q6)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q6)Dec 31, 2022
(FY)Jun 30, 2022
Turnover
8.41%342.35M
9.07%644.43M
6.98%315.79M
-41.02%590.82M
--440.7M
-56.67%295.19M
--141.2M
-10.70%1B
75.34%681.27M
71.34%1.12B
Operating income
8.41%342.35M
9.07%644.43M
6.98%315.79M
-41.02%590.82M
-56.67%295.19M
-10.70%1B
75.34%681.27M
71.34%1.12B
Cost of sales
-9.46%-182.88M
-8.73%-348.97M
-8.01%-167.07M
21.43%-320.97M
----
27.53%-154.68M
----
11.60%-408.51M
-23.34%-213.43M
-66.21%-462.11M
Operating expenses
-9.46%-182.88M
-8.73%-348.97M
-8.01%-167.07M
21.43%-320.97M
27.53%-154.68M
11.60%-408.51M
-23.34%-213.43M
-66.21%-462.11M
Gross profit
7.23%159.47M
9.49%295.46M
5.84%148.72M
-54.51%269.85M
-69.97%140.51M
-10.07%593.24M
117.10%467.84M
75.13%659.69M
Administrative expenses
-4.91%-135.18M
-2.90%-271.67M
-5.60%-128.85M
24.12%-264.02M
----
10.76%-122.02M
----
-43.89%-347.96M
-27.02%-136.73M
-4.86%-241.83M
Operating interest expense
----
----
----
----
----
----
----
----
-276.68%-4.14M
-0.07%-2.93M
Special items of operating profit
-61.09%1.41M
-57.19%12.94M
-65.55%3.61M
793.09%30.22M
----
1,576.34%10.48M
----
-89.53%3.38M
-138.25%-710K
30.86%32.32M
Operating profit
9.44%25.69M
1.87%36.73M
-18.97%23.48M
-85.50%36.06M
-91.12%28.97M
-44.40%248.66M
200.39%326.27M
166.48%447.24M
Financing cost
-1.86%-3.29M
20.32%-6.55M
24.44%-3.23M
0.93%-8.22M
----
---4.28M
----
---8.3M
----
----
Share of profits of associates
241.34%253K
81.27%-238K
76.45%-179K
17.63%-1.27M
----
35.32%-760K
----
21.95%-1.54M
-202.84%-1.18M
-299.70%-1.98M
Earning before tax
12.90%22.65M
12.72%29.94M
-16.16%20.07M
-88.88%26.56M
-92.64%23.93M
-46.37%238.82M
200.38%325.09M
163.75%445.26M
Tax
-15.78%-3.76M
-39.37%-3.31M
16.84%-3.24M
95.90%-2.38M
----
93.15%-3.9M
----
17.12%-57.98M
-220.15%-56.98M
-187.08%-69.95M
After-tax profit from continuing operations
12.34%18.9M
10.10%26.63M
-16.03%16.82M
-86.62%24.19M
-92.53%20.03M
-51.82%180.84M
196.49%268.11M
159.81%375.31M
Earning after tax
12.34%18.9M
10.10%26.63M
-16.03%16.82M
-86.62%24.19M
-92.53%20.03M
-51.82%180.84M
196.49%268.11M
159.81%375.31M
Minority profit
--646K
--296K
----
----
----
----
----
----
----
----
Profit attributable to shareholders
8.50%18.25M
8.88%26.34M
-16.03%16.82M
-86.62%24.19M
-92.53%20.03M
-51.82%180.84M
196.49%268.11M
159.81%375.31M
Basic earnings per share
9.09%0.048
7.81%0.069
-16.98%0.044
-86.55%0.064
-92.49%0.053
-51.87%0.476
196.64%0.706
159.58%0.989
Diluted earnings per share
9.09%0.048
7.81%0.069
-16.98%0.044
-86.55%0.064
-92.49%0.053
-51.87%0.476
196.64%0.706
159.58%0.989
Currency Unit
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
HKD
Accounting Standards
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
HKAS
Audit Opinions
--
Unqualified Opinion
--
Unqualified Opinion
--
--
--
Unaudited opinion
--
Unqualified Opinion
Auditor
--
Ernst & Young
--
Ernst & Young
--
--
--
Ernst & Young
--
Ernst & Young
(Q6)Dec 31, 2025(FY)Jun 30, 2025(Q6)Dec 31, 2024(FY)Jun 30, 2024(Q9)Mar 31, 2024(Q6)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q6)Dec 31, 2022(FY)Jun 30, 2022
Turnover 8.41%342.35M9.07%644.43M6.98%315.79M-41.02%590.82M--440.7M-56.67%295.19M--141.2M-10.70%1B75.34%681.27M71.34%1.12B
Operating income 8.41%342.35M9.07%644.43M6.98%315.79M-41.02%590.82M-56.67%295.19M-10.70%1B75.34%681.27M71.34%1.12B
Cost of sales -9.46%-182.88M-8.73%-348.97M-8.01%-167.07M21.43%-320.97M----27.53%-154.68M----11.60%-408.51M-23.34%-213.43M-66.21%-462.11M
Operating expenses -9.46%-182.88M-8.73%-348.97M-8.01%-167.07M21.43%-320.97M27.53%-154.68M11.60%-408.51M-23.34%-213.43M-66.21%-462.11M
Gross profit 7.23%159.47M9.49%295.46M5.84%148.72M-54.51%269.85M-69.97%140.51M-10.07%593.24M117.10%467.84M75.13%659.69M
Administrative expenses -4.91%-135.18M-2.90%-271.67M-5.60%-128.85M24.12%-264.02M----10.76%-122.02M-----43.89%-347.96M-27.02%-136.73M-4.86%-241.83M
Operating interest expense ---------------------------------276.68%-4.14M-0.07%-2.93M
Special items of operating profit -61.09%1.41M-57.19%12.94M-65.55%3.61M793.09%30.22M----1,576.34%10.48M-----89.53%3.38M-138.25%-710K30.86%32.32M
Operating profit 9.44%25.69M1.87%36.73M-18.97%23.48M-85.50%36.06M-91.12%28.97M-44.40%248.66M200.39%326.27M166.48%447.24M
Financing cost -1.86%-3.29M20.32%-6.55M24.44%-3.23M0.93%-8.22M-------4.28M-------8.3M--------
Share of profits of associates 241.34%253K81.27%-238K76.45%-179K17.63%-1.27M----35.32%-760K----21.95%-1.54M-202.84%-1.18M-299.70%-1.98M
Earning before tax 12.90%22.65M12.72%29.94M-16.16%20.07M-88.88%26.56M-92.64%23.93M-46.37%238.82M200.38%325.09M163.75%445.26M
Tax -15.78%-3.76M-39.37%-3.31M16.84%-3.24M95.90%-2.38M----93.15%-3.9M----17.12%-57.98M-220.15%-56.98M-187.08%-69.95M
After-tax profit from continuing operations 12.34%18.9M10.10%26.63M-16.03%16.82M-86.62%24.19M-92.53%20.03M-51.82%180.84M196.49%268.11M159.81%375.31M
Earning after tax 12.34%18.9M10.10%26.63M-16.03%16.82M-86.62%24.19M-92.53%20.03M-51.82%180.84M196.49%268.11M159.81%375.31M
Minority profit --646K--296K--------------------------------
Profit attributable to shareholders 8.50%18.25M8.88%26.34M-16.03%16.82M-86.62%24.19M-92.53%20.03M-51.82%180.84M196.49%268.11M159.81%375.31M
Basic earnings per share 9.09%0.0487.81%0.069-16.98%0.044-86.55%0.064-92.49%0.053-51.87%0.476196.64%0.706159.58%0.989
Diluted earnings per share 9.09%0.0487.81%0.069-16.98%0.044-86.55%0.064-92.49%0.053-51.87%0.476196.64%0.706159.58%0.989
Currency Unit HKDHKDHKDHKDHKDHKDHKDHKDHKDHKD
Accounting Standards HKASHKASHKASHKASHKASHKASHKASHKASHKASHKAS
Audit Opinions --Unqualified Opinion--Unqualified Opinion------Unaudited opinion--Unqualified Opinion
Auditor --Ernst & Young--Ernst & Young------Ernst & Young--Ernst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More